In bladder cancer, the over-expression of EGFR has been widely reported [55], [56], [57], [58], [59] and several studies have shown EGFR positivity to be associated with high tumor stage, tumor progression, and poor clinical outcome [55], [57]. This evidence concerns the gene EGFR and urinary bladder carcinoma.